Jaguar Health (JAGX) Cash from Operations (2014 - 2026)
Jaguar Health (JAGX) reported Cash from Operations of 8830000.0 for Q1 2026, up 220.73% year-over-year from 2753117.06 in Q1 2025, and up 260.9% quarter-over-quarter from 5488000.0 in Q4 2025.
Jaguar Health (JAGX) Cash from Operations (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Cash from Operations data on file, last reported at 8830000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 8830000.0, up 220.73% year-over-year; the trailing twelve-month figure through Mar 2026 was 7542000.0 (up 74.56% YoY), and the FY2025 annual result was 23686000.0, up 19.39% from the prior year.
- Cash from Operations climbed to 8830000.0 in Q1 2026 per JAGX's latest filing, from 5488000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 8830000.0 in Q1 2026 and troughed at 10457000.0 in Q2 2022.
- A 5-year average of 6505058.82 and a median of 7314000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations declined 29.24% in 2023, then surged 220.73% in 2026.
- A 5-year view of Cash from Operations shows it stood at 6423000.0 in 2022, then dropped by 16.0% to 7451000.0 in 2023, then decreased by 5.03% to 7826000.0 in 2024, then rose by 29.87% to 5488000.0 in 2025, then surged by 260.9% to 8830000.0 in 2026.
- Business Quant data shows JAGX's Cash from Operations at 8830000.0 in Q1 2026, 5488000.0 in Q4 2025, and 4689000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 8.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.83 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2025 | -5.49 Mn |
| Dec 31, 2025 | -5.49 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Dec 31, 2023 | -7.45 Mn |
| Dec 31, 2023 | -7.45 Mn |